Back to Search Start Over

Development of a novel prostate Cancer-Stroma Sphere (CSS) model for In Vitro tumor microenvironment studies

Authors :
Aigul R. Rakhmatullina
Maria A. Zolotykh
Yulia V. Filina
Rimma N. Mingaleeva
Aisylu R. Sagdeeva
Eugenia A. Boulygina
Dina U. Gafurbaeva
Emil R. Bulatov
Albert A. Rizvanov
Regina R. Miftakhova
Source :
Translational Oncology, Vol 44, Iss , Pp 101930- (2024)
Publication Year :
2024
Publisher :
Elsevier, 2024.

Abstract

Tumor employs non-cancerous cells to gain beneficial features that promote growth and survival of cancer cells. Despite intensive research in the area of tumor microenvironment, there is still a lack of reliable and reproducible in vitro model for tumor and tumor-microenvironment cell interaction studies. Herein we report the successful development of a heterogeneous cancer-stroma sphere (CSS) model composed of prostate adenocarcinoma PC3 cells and immortalized mesenchymal stem cells (MSC). The CSS model demonstrated a structured spatial layout of the cells, with stromal cells concentrated at the center of the spheres and tumor cells located on the periphery. Significant increase in the levels of VEGFA, IL-10, and IL1a has been detected in the conditioned media of CSS as compared to PC3 spheres. Single cell RNA sequencing data revealed that VEGFA was secreted by MSC cells within heterogeneous spheroids. Enhanced expression of extracellular membrane (ECM) proteins was also shown for CSS-derived MSCs. Furthermore, we demonstrated that the multicellular architecture altered cancer cell response to chemotherapeutic agents: the inhibition of sphere formation by topotecan was 74.92 ± 4.56 % for PC3 spheres and 45.95 ± 7.84 % for CSS spheres (p < 0.01), docetaxel showed 37,51± 20,88 % and 15,67± 14,08 % inhibition, respectively (p < 0.05). Thus, CSS present an effective in vitro model for examining the extracellular matrix composition and cell-to-cell interactions within the tumor, as well as for evaluating the antitumor activity of drugs.

Details

Language :
English
ISSN :
19365233
Volume :
44
Issue :
101930-
Database :
Directory of Open Access Journals
Journal :
Translational Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.2237a3f909a847f387532243097f86cf
Document Type :
article
Full Text :
https://doi.org/10.1016/j.tranon.2024.101930